TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- Rockcliffe Capital is pleased to announce today the initiation of equity research coverage on Wheaton Precious Metals Corp. (TSX/NYSE: WPM), the world's premier precious metals streaming company known for its top-tier asset portfolio, strong balance sheet, and robust cash flow generation.
Please see below information about transactions made under the second tranche of the 2025 share buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO).
Aalberts today reports that it has repurchased 99,111 of its own shares in the period from 16 June 2025, up to and including 20 June 2025, for an amount of EUR 2,939,682.20, so at an average share price of EUR 29.66.
NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of UnitedHealth Group Incorporated (NYSE: UNH), Bitfarms Ltd. (NASDAQ: BITF), and Reddit, Inc. (NYSE:RDDT). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Highlights of the fiscal year ended May 31, 2025
Share value of $16.70, down $0.03 from the value established following the 6-month period ended November 30, 2024...
MELBOURNE, Australia and INDIANAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces five abstract presentations and two satellite symposia featuring its developmental theranostic programs and commercial products at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025 Annual Meeting being held in New Orleans, Louisiana (U.S.) from June 21 – 24.
Earnings per share ("EPS") and adjusted EPS(1)(2) of $0.74Prior year EPS and adjusted EPS of $0.61 and $0.63, respectivelyDelivered adjusted EPS growth of 8.8%...
MELVILLE, N.Y., June 17, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced that its Board of Directors has authorized a stock repurchase program under which the Company may repurchase up to $2 million of its outstanding common stock through June 16, 2026.
Please see below information about transactions made under the buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR) for shares to be used in the share-based incentive programmes for employees and management.
PHILADELPHIA, June 16, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Open Lending Corporation ("Open...
Oslo, 16 June 2025: Scatec ASA (“The Company”) is continuing its Employee Share Purchase Programme established in 2019. The participants are offered to purchase shares with a subscription value of between NOK 10,413 and NOK 104,128. Employees are offered a price reduction of 25 percent of the subscription value in exchange for the shares being subject to a two-year lock-up period.